Virtual Reality in Reducing Acute Orthopedic Pain
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Fractures
- Sponsor
- Mayo Clinic
- Enrollment
- 100
- Primary Endpoint
- opioid use
- Status
- Not Yet Recruiting
- Last Updated
- 4 months ago
Overview
Brief Summary
The primary aim of this research is to show that a virtual reality (VR) service line is feasible and can sustain itself with the ability to take care of patients. Additionally, the investigators aim to learn about the limitations of a service line and provide a pathway for future improvements in building a VR service line that is optimally aligned with the user's needs. Secondary aims are to evaluate the clinical aspects of the patient's outcomes including length of stay, morphine equivalents in pain medicine required during the hospital stay, and user experiences.
Investigators
Scott A. Helgeson
Consultant, Assistant Professor of Medicine
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
- •Hospitalized with an orthopedic fracture
- •Able to participate fully in all aspects of the study
- •Able to understand and sign informed consent
- •Individuals with unaided vision or those who can correct their vision using contact lenses
Exclusion Criteria
- •Non-English speaking
- •Self-reported history of acute and/or chronic severe motion sickness
- •The presence of a facial/head deformity that will prohibit the wearing of a VR head mounted display.
- •Legally blind or deaf
- •Have had a seizure within the past 1 year
- •Have current (within the past 30 days) clinically significant acute or chronic progressive or unstable/uncontrolled neurologic disorder
- •Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence
Outcomes
Primary Outcomes
opioid use
Time Frame: From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks
Change in opioid equivalents during hospital stay from hospital admission to discharge
Secondary Outcomes
- reduction in anxiolytics(From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks)
- hospital length of stay(From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks)
- reduction in sleep aids prescribed(From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks)
- User experiences(obtained once on the day of hospital discharge, up to 5 weeks from study enrollment)